News

Osteonecrosis

Editorial Bioteck

17 October 2025

Osteonecrosis of the femoral head: a clinical trial

Today we present a retrospective clinical study published in 2016, involving 19 patients with osteonecrosis of the femoral head.

 

The patients underwent FVFG (Free Vascularized Fibular Grafting Tecnhique) surgery, combined with the mixture of autologous bone tissue from the greater trochanter and Osteoplant Activagen Injectable Paste® bone graft.

 

Osteoplant Activagen Injectable Paste® is an injectable bone paste that adapts easily to the shape of the defect and to be used in combination with granular components.
In addition, Osteoplant Activagen Injectable Paste® collagen component enhances graft adhesion upon contact with blood.

 

The study results indicated that the Bioteck bone graft effectively filled the cavity left by the removal of necrotic bone tissue.

 

Radiographic analysis confirmed the formation of new bone tissue…

 

> Read the full case here

 

Logo Bioteck Academy


Vicenza
Headquarter
via E. Fermi, 49
36057 Arcugnano, Vicenza (VI) - Italy
Tel. +39 0444 289366
Fax: +39 0444 285272


Contact us


Torino
Multi-function production center
Via G. Agnelli, 3
10020 Riva presso Chieri, Torino (TO) - Italy

Copyright © 2026 Bioteck S.p.A. - Privacy Policy - Cookie Policy